Anti-HER2 CAR-T
/ UTC Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 16, 2025
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
(clinicaltrials.gov)
- P=N/A | N=30 | Recruiting | Sponsor: UTC Therapeutics Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
October 28, 2024
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
(clinicaltrials.gov)
- P=N/A | N=30 | Not yet recruiting | Sponsor: UTC Therapeutics Inc.
New trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1